In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Category: Generic Brands and Products
-
Ozempic Is About to Go Generic in India, China and Canada
The New York Times – Business: -
The Workers Left Out of Trump’s Drug-Manufacturing Renaissance
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines.
-
Why Medicare Recipients Should Check Their 2026 Drug Plans Now
Fall enrollment is on. Some plans are raising premiums for Part D, which covers prescriptions, by $50 or more per month, while others are lowering them.
-
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs
The agency announced moves to cut regulatory obstacles for the makers of biosimilar drugs, which are akin to generics and may help lower drug costs.
-
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
-
F.D.A. Approves a New Generic Abortion Pill
The decision enraged opponents of abortion, who have been pressuring the administration to restrict access to abortion medication.
-
How Trump’s Online Drugstore May Affect Your Drug Costs
President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.
-
Philanthropies Strike a Promising Deal to Turn Back H.I.V.
Low- and middle-income countries will be able to purchase an effective preventative at a reduced price. The arrangements may help stem the epidemic 40 years after it began.
-
F.D.A.’s Approval of Drug for Autism Upends Review Process
The agency revived an old treatment for cancer patients, unilaterally approving it for a subset of people with autism. Experts worry that the narrower scope will get lost in the hype.
-
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Them
President Trump’s planned pharmaceutical tariffs threaten to hit many of the most common and well-known drugs that Americans take.
-
Aldi’s Passionate, Cultlike Following Fuels Its Rapid Expansion Plans
“It feels like I’m at a bougie store, but I’m not paying bougie prices,” one shopper said of the discount grocer, which is set to open hundreds of stores as consumers look to save and buy organic.
-
Snack Maker Sues Aldi Grocery Chain Over Look-Alike Product Packaging
Mondelez International, a corporate giant behind the name-brand versions of many snacks, contends that Aldi is mimicking its packaging to dupe customers.